BCDA Stock Catalyst: BioCardia Patent Issued for Cardiac Cell Therapy

Jun 6, 2024 · 3:47pm ET

The patent enhances BioCardia's intellectual property portfolio.

Max move

+70.6%

High of day $7.44

Sparker timei

3:47pm ET

BCDA · Jun 6, 2024

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

BioCardia, Inc. announced on June 7, 2024, that it has been granted a patent for its cardiac cell therapy technology. The patent issuance strengthens the company's intellectual property portfolio, providing additional protection for its innovative therapies.

The newly issued patent covers specific methods and compositions used in BioCardia's cell therapy treatments aimed at addressing heart disease. This development is expected to support the company's ongoing research and development efforts in the biotechnology sector.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time BCDA sparks.

Download Sniper App →

Catch the next BCDA-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →